Du Huo Ji Sheng Tang Tested at Molecular Level
Duhuo Jisheng Decoction (DHJSD) is a traditional Chinese herbal
medicine that has multiple uses, including as a treatment for osteoarthritis
(OA). However, the molecular mechanisms underlying the therapeutic effects of
DHJSD on OA remain unknown. In the present study, a serum pharmacological
method was applied to investigate the effects of DHJSD on the proliferation of
chondrocytes treated with interleukin‑1β (IL‑1β) in vitro. This is a cell
model commonly used to reproduce the mechanisms involved in degenerative
arthropathies, including OA. The most effective intervention conditions of
DHJSD serum were examined by MTT assay. The degenerative chondrocyte model was
established by IL‑1β‑culture for 24 h, and was verified by optical
microscopy and immunohistochemical analyses. Following the successful
establishment of the degenerative chondrocyte model, the chondrocytes were
subsequently randomly divided into two groups: The blank serum group and the
DHJSD treatment group. Subsequent to treatment with the corresponding serum,
cell proliferation was detected by MTT assay and DNA staining followed by FACS
analysis, and the mRNA and protein expression levels of cyclin D1, cyclin‑dependent
kinase 4 (CDK4), retinoblastoma tumor suppressor protein (Rb) and p16 were
measured by reverse transcription polymerase chain reaction and western
blotting, respectively. The results indicated that the most effective condition
for the promotion of chondrocyte proliferation was 10% concentration of DHJSD 2‑h
serum, and the degenerative chondrocyte model was successfully reproduced by IL‑1β‑treatment
for 24 h. The mRNA and protein expression levels of cyclin D1, CDK4
and Rb in the DHJSD serum‑treated cells were significantly increased compared
with those in the blank serum group, whereas p16 expression was significantly
downregulated. These results indicate that treatment of cells with DHJSD‑containing
serum is able to promote IL‑1β‑induced chondrocyte proliferation by promoting
G1/S phase transition via modulating the expressions of cyclin D1,
CDK4, Rb and p16, which contribute to the clinical efficacy of DHJSD in OA.
Source: Wu G,
Fan H,
Huang Y,
Zheng C,
Ye J,
Liu X.
Duhuo Jisheng
Decoction‑containing serum promotes proliferation of interleukin‑1β‑induced
chondrocytes through the p16‑cyclin D1/CDK4‑Rb pathway. Mol Med Rep. 2014 Sep 2.
No comments:
Post a Comment